Abnormal Investor Visits (AIV, 异常机构调研信号)
The cross-sectional residual of institutional on-site visit frequency after stripping out the expected component driven by firm size, liquidity, and past performance. On SZSE-listed A-shares (2012–2019), AIV is a positive cross-sectional alpha proxy that survives standard controls and Fama-French 5-factor adjustment.
Definition
For firm i and calendar month m, let
\text{LNVISIT}_{im} = \log\bigl(1 + \#\text{on-site investor visits in months } m-2, m-1, m\bigr) Run the monthly cross-sectional regression \text{LNVISIT}_{im} = \alpha_m + \beta_1\,\text{SIZE}_{im} + \beta_2\,\text{TURN}_{im} + \beta_3\,\text{MOMEN}_{im} + \beta_4\,\text{ROA}_{im} + \varepsilon_{im}
with
- \text{SIZE}_{im} = log(circulation market cap in CNY millions)
- \text{TURN}_{im} = 12-month average share turnover
- \text{MOMEN}_{im} = trailing 12-month cumulative return (skip month m)
- \text{ROA}_{im} = operating income / total assets
Define
\text{AIV}_{im} \;\equiv\; \hat\varepsilon_{im}.
\text{AIV} > 0 means the firm was visited more often than its size, liquidity, momentum, and profitability would predict. The signal is published monthly; in the original So Wang Zhang 2024 Investor Corporate Visits paper it is winsorised cross-sectionally at 1/99% before use.
Empirical properties (SZSE, 2012-07 to 2019-12)
| Metric | Equal-weighted | Value-weighted |
|---|---|---|
| Raw Q5−Q1 return | 1.14% / month (t = 5.52) | 0.65% / month (t = 2.92) |
| Market-adjusted | 1.14% (t = 5.52) | 0.65% (t = 2.92) |
| DGTW-adjusted | 0.66% (t = 4.92) | 0.39% (t = 2.64) |
| FF5 α | 1.02% (t = 7.86) | 0.71% (t = 3.84) |
| Annualised raw | ~13.7% | ~7.8% |
Lagged AIV predicts returns for 6 (VW) to 10 (EW) months without sign reversal — inconsistent with transient price pressure.
Where the alpha concentrates
The signal is stronger when (all interactions significantly positive):
- The firm is neglected — low analyst coverage, low institutional ownership, recent losses, or small size (Table 5 Panel B).
- Trading volume is low — combining high-AIV / low-abnormal-turnover with low-AIV / high-abnormal-turnover yields ~1.49% / month DGTW-adjusted alpha (Table 6).
- The visiting institution is paying higher costs — non-holder visits, initial visits (no visit in past 6 months), or above-median travel time from Baidu Map API (Table 5 Panel A).
- Public attention is low — interaction terms with analyst revisions and media/analyst attention are significantly negative.
The signal is not subsumed by:
- Standard cross-sectional controls (size, B/M, momentum, profitability, asset growth, turnover, reversal) — Table 3 col 3.
- Abnormal analyst coverage (Lee & So 2017's A_{TOT}) — Table 3 col 3-4.
- Average signed returns around visits (Cheng et al. 2019's AVG_SAR) — Table 3 col 4.
- Lagged / contemporaneous / forward mutual-fund holdings (column 7 even intentionally includes a forward-looking fund-holding control) — Table 3 cols 5-7.
- Sell-side-analyst visits (AIV_NOFUND has no incremental power) — Table 3 col 8.
- Information risk (VPIN, bid-ask spread) — Internet Appendix A1; both proxies are negatively correlated with AIV.
Mechanism
AIV predicts subsequent earnings news (Table 7): positive on standardised unexpected earnings (SUE), earnings-announcement size-adjusted returns (SAR), analyst forecast errors (FE), and analyst revisions (REV). Hedge returns are 3.6–4× larger on the next earnings-announcement day than on non-announcement days. AIV also precedes institutional buying (Table 8): holdings of visiting funds rise with AIV while holdings of non-visiting funds fall — direct evidence of informed trading capitalising the signal into price.
AIV does NOT survive when the visit is moved online: post-COVID online AIV has no return predictability, consistent with the costly-information story.
Relationship to other "abnormal attention" factors
| Factor | Underlying attention measure | Universe |
|---|---|---|
| A_{TOT} (Lee & So 2017) | Analyst coverage residual | US equity |
| AIV (So, Wang & Zhang 2024) | Buy-side on-site visit residual | SZSE-listed A-shares |
| Information-acquisition proxy (Crane, Crotty & Umar 2023) | Hedge-fund info-acquisition activity | US equity |
All three follow the same template — strip out the mechanical component driven by size / liquidity / past returns from a flow-based attention measure, take the residual. The deep mechanism differs (analyst coverage is a free public good, AIV is a costly private vetting, hedge-fund info acquisition is a paid service).
Implementation notes
- Use the disclosure date, not the visit date — ~88.9% of visits are disclosed within the mandated 2-day window.
- The signal is published in real time on
irm.cninfo.com.cn/szse/(互动易). A-share data vendors (CSMAR, Wind) carry a cleaned version. - Combine with a size / liquidity screen: alpha concentrates in small / illiquid names — typical of an attention / neglect story.
- Crowding risk: once the paper is published and the signal is widely replicated, expect the EW alpha to compress. Realistic OOS expectation is roughly half the in-sample.
Limitations and open questions
- SZSE-only; no Shanghai counterpart because the SHSE does not require same-day disclosure.
- No transaction-cost layer; turnover of the quintile-5 minus quintile-1 portfolio and A-share commissions / impact / stamp duty are not modelled.
- The "abnormal" definition is deliberately parsimonious (4 controls); sector, geographic-cluster, or institutional-coverage fixed effects might further reduce the residual variance but should not change the sign.
- Combination with Cross-Sectional Momentum or Time-Series Momentum is unexplored.
See also
- So Wang Zhang 2024 Investor Corporate Visits — source paper.
- Investor Corporate Site Visits — the underlying behaviour.
- Shenzhen Stock Exchange Disclosure Regime — the institutional rule that makes the signal observable.
- Costly Information Acquisition — the general principle.
- Neglected Stocks — where the alpha concentrates.
- Post-Earnings Announcement Drift — the release channel through which the alpha realises.
- Investor Attention — broader family of attention-based alpha factors.